We have further tested the correlation of PD-L1 expression obtained with SP263 antibody in FFPE tissues with hormone receptor status of breast cancer, known prognostic markers to correlate with PD-L1 expression in breast cancer. This evidence concerns the gene NR4A1 and breast carcinoma.